Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

LAN Long-jiang, LIU Quan-rong. Preliminary clinical observation of DF-521 in treatment of sudden deafness[J]. Journal of Pharmaceutical Practice and Service, 2004, (1): 14-15.
Citation: LAN Long-jiang, LIU Quan-rong. Preliminary clinical observation of DF-521 in treatment of sudden deafness[J]. Journal of Pharmaceutical Practice and Service, 2004, (1): 14-15.

Preliminary clinical observation of DF-521 in treatment of sudden deafness

  • Received Date: 2003-08-21
  • Objective To investigate the effect of application of DF-521 on sudden deafness.Methods One hundred and eighteen patients(130 ears) with sudden deafness were randomly divided into two groups(DF-521 group and control group), Beside intravenous adiministration of DF-521, another treatments in DF-521 group were the same as that in control group including 6% Dextran-40, Salvia Miltiorrhiza, TTFD,ATP,CoA and dexamethasone.Result The total efficacy of DF-521 group was 85.0% and total efficacy of control group(P<0.05) was 65.0%.Conclusion The application of DF-521 can significantly improve the effect of treatment on sudden deafness.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2159) PDF downloads(1018) Cited by()

Related
Proportional views

Preliminary clinical observation of DF-521 in treatment of sudden deafness

Abstract: Objective To investigate the effect of application of DF-521 on sudden deafness.Methods One hundred and eighteen patients(130 ears) with sudden deafness were randomly divided into two groups(DF-521 group and control group), Beside intravenous adiministration of DF-521, another treatments in DF-521 group were the same as that in control group including 6% Dextran-40, Salvia Miltiorrhiza, TTFD,ATP,CoA and dexamethasone.Result The total efficacy of DF-521 group was 85.0% and total efficacy of control group(P<0.05) was 65.0%.Conclusion The application of DF-521 can significantly improve the effect of treatment on sudden deafness.

LAN Long-jiang, LIU Quan-rong. Preliminary clinical observation of DF-521 in treatment of sudden deafness[J]. Journal of Pharmaceutical Practice and Service, 2004, (1): 14-15.
Citation: LAN Long-jiang, LIU Quan-rong. Preliminary clinical observation of DF-521 in treatment of sudden deafness[J]. Journal of Pharmaceutical Practice and Service, 2004, (1): 14-15.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return